International Journal of Rheumatology / 2019 / Article / Tab 4 / Research Article
The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome Table 4 Endoscopic gastric mucosal changes in the examined patients and detection rates of H. pylori .
Gastric mucosa status at endoscopy PAPS SLE+APS SLE All patients n = 20 n = 26 n = 39 n = 85 H. pylori (+)H. pylori (-)H. pylori (+)H. pylori (-)H. pylori (+)H. pylori (-)H. pylori (+)H. pylori (-)n = 14 (70.0%) n = 6 (30.0%) n = 21 (80.8%) n = 5 (19.2%) n = 31 (79.5%) n = 8 (20.5%) n = 66 (77.6%) n = 19 (22.4%) All patients with gastric mucosal changes, n (%) 12 (85.7) 6 (100) 21 (100) 5 (100) 28 (90.3) 5 (62.5) 61 (92.4) 16 (84.2) Antral gastritis, n (%) 11 (78.6) 6 (100) 20 (95.2) 5 (100) 23 (74.2) 5 (62.5) 54 (81.8) 16 (84.2) Pangastritis, n (%) 1 (7.1) 0 1 (4.8) 0 5 (16.6) 0 7 (10.6) 0 Gastric mucosal erosion, n (%) 5 (35.7) 0 7 (33.3) 3 (60.0) 5 (16.6) 1 (12.5) 17 (25.6) 4 (21,2) Gastric mucosal hemorrhage, n (%) 1 (7.1) 1 (16.7) 2 (9.5) 1 (20.0) 2 (6.4) 0 5 (7.6) 2 (10.5) Intact gastric mucosa, n (%) 2 (14.3) 0 0 0 3 (10.0) 3 (33.3) 5 (7.8) 3 (14.3)
Note : H. pylori was detected by PCR.